453 related articles for article (PubMed ID: 31997506)
1. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
[TBL] [Abstract][Full Text] [Related]
3. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
[TBL] [Abstract][Full Text] [Related]
4. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen,
Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö
Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491
[No Abstract] [Full Text] [Related]
5. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
6. Analysis of differentially expressed genes in oral epithelial cells infected with Fusobacterium nucleatum for revealing genes associated with oral cancer.
Zhang S; Li C; Zhang Z; Li Y; Li Q; Geng F; Liu J; Pan Y
J Cell Mol Med; 2021 Jan; 25(2):892-904. PubMed ID: 33289330
[TBL] [Abstract][Full Text] [Related]
7. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
Zhang H; Sun JD; Yan LJ; Zhao XP
Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
[TBL] [Abstract][Full Text] [Related]
8. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
10. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
11.
Geng F; Zhang Y; Lu Z; Zhang S; Pan Y
DNA Cell Biol; 2020 Jan; 39(1):144-151. PubMed ID: 31765243
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS5 suppresses proliferation, migration, invasion, and epithelial-mesenchymal transition in oral squamous cell carcinoma by regulating the miR-21/PTEN axis.
Zeng B; Li Y; Jiang F; Wei C; Chen G; Zhang W; Zhao W; Yu D
Exp Cell Res; 2019 Jan; 374(2):365-373. PubMed ID: 30576678
[TBL] [Abstract][Full Text] [Related]
13. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
14. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum.
Despins CA; Brown SD; Robinson AV; Mungall AJ; Allen-Vercoe E; Holt RA
mBio; 2021 Oct; 12(5):e0206221. PubMed ID: 34700376
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
17. SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.
Xu M; Wang J; Xu Z; Li R; Wang P; Shang R; Cigliano A; Ribback S; Solinas A; Pes GM; Evert K; Wang H; Song X; Zhang S; Che L; Pascale RM; Calvisi DF; Liu Q; Chen X
Cancer Res; 2019 Nov; 79(21):5563-5574. PubMed ID: 31383647
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
Front Oncol; 2021; 11():661288. PubMed ID: 34532282
[TBL] [Abstract][Full Text] [Related]
19. The effect and mechanism of miR-30e-5p targeting SNAI1 to regulate epithelial-mesenchymal transition on pancreatic cancer.
Liang Z; Tang S; He R; Luo W; Qin S; Jiang H
Bioengineered; 2022 Apr; 13(4):8013-8028. PubMed ID: 35300562
[TBL] [Abstract][Full Text] [Related]
20. LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ.
Shen W; Zhang J; Pan Y; Jin Y
J Clin Lab Anal; 2021 Dec; 35(12):e24066. PubMed ID: 34714963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]